Orthopaedic specialist Stryker has said it is “disappointed” by a US federal grand jury indictment that accuses the company’s biotech division and several employees of improper marketing practices and intentionally defrauding the Food and Drug Administration1,2
...
Regulatory Affairs Medtech
Stryker biotech division hit by fraud charges in US
04 November 2009
Joseph Harvey
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Medtech
EVENTS
21September 2009
Minneapolis (MN), US
